Michael Blaha, MD, MPH

Michael Blaha

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: MedImmune, Inc(MODEST), Siemens(SIGNIFICANT), Regeneron(MODEST), Sanofi(MODEST), Akcea(MODEST), Amgen(MODEST), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen Inc.(NONE), Aetna(NONE)

View Full Disclosure